Showing results (161-170 of 202) with videos related to

Sort By:
Pageof 21
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2000
Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implicationsF Andre, D Grunenwald, J P Pignon, et al.
Cancer|November 15, 1986
Cardiac metastases. Case report on an isolated cardiac metastasis of a myxoid liposarcomaJ L Lagrange, P Despins, M Spielman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2004
Treatment of advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an European Experts PanelC Gridelli, A Ardizzoni, T Le Chevalier, et al.
Presse Medicale (Paris, France : 1983)|March 21, 1987
[Initial chemotherapy in the treatment of inflammatory breast cancers. 230 cases]J Rouëssé, M Spielmann, T Le Chevalier, et al.
International Journal of Radiation Oncology, Biology, Physics|November 1, 1990
Alternating radiotherapy and chemotherapy in 173 consecutive patients with limited small cell lung carcinoma. GROP and the French Cancer Center's Lung GroupR Arriagada, T le Chevalier, P Ruffie, et al.
Bulletin Du Cancer|January 1, 1989
Limited small cell lung cancer: possible prognostic impact of initial chemotherapy dosesR Arriagada, H de The, T Le Chevalier, et al.
British Journal of Cancer|June 1, 1994
Phase II study of nitrosourea fotemustine as single-drug chemotherapy in poor-prognosis non-small-cell lung cancerJ L Pujol, A Monnier, J Berille, et al.
Presse Medicale (Paris, France : 1983)|May 25, 1985
[Alternating chemotherapy and radiotherapy in the induction treatment of small cell bronchial carcinoma (forms limited to the thorax)]T Le Chevalier, R Arriagada, P Baldeyrou, et al.
Cancer Treatment Reports|June 1, 1985
Phase II study of elliptinium in advanced breast cancerJ G Rouësse, T Le Chevalier, P Caille, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Pilot study of neoadjuvant ifosfamide, cisplatin, and etoposide in locally advanced non-small cell lung cancerJ L Pujol, J F Rossi, T Le Chevalier, et al.
Pageof 21